Crystal structure of SARS-CoV-2 papain-like protease

Gao, Xiaopan, Qin, Bo, Chen, Pu, Zhu, Kaixiang, Hou, Pengjiao, Wojdyla, Justyna Aleksandra, Wang, Meitian, Cui, Sheng·2021·Acta Pharmaceutica Sinica B
DOI 10.1016/j.apsb.2020.08.014

Cited by (339)

Items 301–339 of 339

  1. Pandemic preparedness through genomic surveillance: Overview of mutations in SARS-CoV-2 over the course of COVID-19 outbreak
    Fares Z. Najar, Chelsea L. Murphy, Evan Linde, Veniamin A. Borin, Huan Wang, Shozeb M Haider, Pratul K. Agarwal · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  2. Targeting multiple SARS-CoV-2 domains by Indian medicinal plants – A Drug repurposing study using molecular docking, ADME-Tox analysis
    Niranjan Nandkumar Patil, Rachna Shashikant Jadhav, Praveen Mallari, Rajesh B. Patil, Bhaskar Saha · 2023 · Research Square
  3. The development of papain‐like protease from SARS‐CoV‐2, a potential drug target for antiviral screening: A review
    Riswanto Napitupulu, Is Helianti, Maimunah Maimunah, Fairuz Andini Fatiningtyas, Amarila Malik · 2023 · Indonesian Journal of Biotechnology
  4. Massive Virtual screening and evaluation of small molecule inhibitors of the Papain-like protease of SARS-CoV-2
    Manuel Isaías Osorio, Osvaldo Yáñez, Mauricio O. Gallardo, Olimpo García‐Beltrán, Fernando Danilo González-Nilo, Jose Manuel Perez-Donoso · 2022 · Research Square
  5. Peptide Mold: A Novel Strategy for Mapping Potential Binding Sites in Protein Targets
    Pritam V. Bagwe, Yogesh Jagtap, Vaibhav N. Ghegade, Janvhi Suresh Machhar, Elvis A. F. Martis, Shreerang V. Joshi, Prashant S. Kharkar · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  6. Predicting anti-COVID-19 potential: in silico analysis of Mauritine compound from Ziziphus-spina christi as a promising papain-like protease (PLpro) inhibitor
    Taufik Muhammad Fakih, Fitrianti Darusman, Riry Apriliani, Syifa Prahayati, Dwi Syah Fitra Ramadhan, Aulia Fikri Hidayat, Aden Dhana Rizkita, Tegar Achsendo Yuniarta · 2024 · Journal of Biomolecular Structure and Dynamics
  7. Azadirachta Indica Phytoconstituents as Novel Inhibitors for Main Proteases of COVID-19: Molecular Dynamics and Simulation Study
    Ubaida Hussain, Fatima Gillani, Laiba Gull, Usman Ahmad, Iram Gull, Saadia Noreen, Muhammad Imran · 2025 · Indus journal of bioscience research.
  8. Undeveloped Region in Target-Strategies and Potential in Antiviral Drug Discovery
    Shaoqing Du, Xinyong Liu, Xueping Hu, Peng Zhan · 2025 · Pharmaceutical Fronts
  9. From Plasmid to Pure Protein: Production and Characterization of SARS-CoV-2 PL pro
    Anna De Falco, Rebecca Greene-Cramer, Ben A. Shurina, Suren Zakian, Thomas Acton, Theresa A. Ramelot, Gaetano Thomas Montelione · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Specificity profiling of SARS-CoV-2 PLpro using proteome-derived libraries of linear peptides suggests secondary preference for basic motifs
    Daniel Vogele, Klemens Fröhlich, Oguz Bolgi, Bettina Mayer, Christoph Peters, Ruth Geiss‐Friedlander, Oliver Schilling · 2026 · Archives of Biochemistry and Biophysics
  11. Molecular Docking and Dynamic Studies of Phytoprinciples of Clausena anisata to Unfold the Protease Inhibitory Effects on SARS-CoV-1 & 2
    Maida Engels S.E., Vijayalakshmi Chinniah, Mohammed Hussain AK · 2025 · Coronaviruses
  12. Mechanistic insights into the inhibition of recombinant hepatitis E virus papain-like cysteine protease by Khaya grandifoliola hydro-Ethanolic extract: UHPLC-MS profiling, enzyme kinetics, computational modeling, and cell-based assays
    Arnaud Fondjo Kouam, Cromwel Tepap Zemnou, Armel Jackson Seukep, Babayemi Olawale Oladejo, Fredy Brice Nemg Simo, Kerinyuy Juliene Kongnyuy, Armelle Gaelle Kwesseu Fepa, Elisabeth Zeuko’o Menkem, Frédéric Nico Njayou, Paul Fewou Moundipa · 2026 · Fitoterapia
  13. Targeting coronaviral nsp14: a bifunctional enzyme for RNA capping and proofreading
    Junbo Wang, Yixiao Liu, Zhiyong Lou · 2025 · Biophysics Reports
  14. Discovery of Inhibitors of SARS-CoV-2 Papain-like Protease Using Molecular Simulation and Markov State Model
    Yue Qiu, Wei Ling Hong, Xiao Wang, Chuan-yu Liao, Shi-Peng Jiang, Huajuan Jiang · 2025 · The Journal of Physical Chemistry A
  15. Additional file 1 of Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
    Nepali, Kunal, Sharma, Ram, Sachin Sharma, Amandeep Thakur, Liou, Jing-Ping · 2022 · Figshare
  16. Additional file 2 of Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases
    Zinuo Chen, Cui, Qinghua, Cooper, Laura, Zhang, Pin, Lee, Hyun, Zhaoyu Chen, Wang, Yanyan, Liu, Xiaoyun, Rong, Lijun, Du, Ruikun · 2021 · Figshare
  17. Additional file 1 of Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases
    Zinuo Chen, Cui, Qinghua, Cooper, Laura, Zhang, Pin, Lee, Hyun, Chen, Zhaoyu, Wang, Yanyan, Liu, Xiaoyun, Rong, Lijun, Du, Ruikun · 2021 · Figshare
  18. Structural and dynamic characterization of SARS-CoV-2 papain-like protease bound to machine-learning-identified oxadiazole inhibitors
    Muhammad Waqas, Li Xuan, Amjad Ali, Haoke Zhang, Zunnan Huang · 2026 · Journal of Molecular Structure
  19. Are Tetrapleura tetraptera Phytochemicals Druggable Against SARS‐CoV‐2 Papain‐Like Protein? A Computational Approach
    Frank Eric Tatsing Foka, Hazel Tumelo Mufhandu · 2026 · New Zealand Journal of Botany
  20. Experience from an HTS campaign: Investigation of susceptibility and rescue of SARS-CoV-2 nsp3 protease assay from metal contamination
    Irene Georgiou, Sandra O’Neill, Colin Robinson, Fraser Cunningham, Sean N. O’Byrne, David W. Gray, Ian Hugh Gilbert, Duncan E. Scott · 2026 · SLAS TECHNOLOGY
  21. Mécanismes d’entrée de SARS-CoV-2 : relation hôte-virus au site de primo-infection et repositionnement thérapeutique
    Margot Morin‐Dewaele · 2023
  22. Targeting SARS-CoV-2 Non-Structural Proteins: A Blueprint for Next-Generation Small-Molecule Coronavirus Antivirals
    Exequiel O. J. Porta, Dana F. AlKharboush, Lauren Jackson, Felix Pang, Aylin Darin, Joy Louka, Mohammed Quamruzzaman, Xinyue Shi, Geoffrey Wells, Frank Kozielski · 2026 · Pharmaceutics
  23. Computational Evaluation of Multitarget Capabilities of Phenylethanoid Glycosides Against SARS-CoV-2’s 3CLpro and PLpro
    Maria Eduarda Alves Esteves, Bruce Veiga Andriolo, Caio Felipe de Araujo Ribas Cheohen, Thamirys Silva da Fonseca, Mariana Freire Campos, Carla Monteiro Leal, Diego Allonso, Gilda Guimarães Leitão, Suzana Guimarães Leitão, Manuela Leal da Silva · 2026 · Pharmaceuticals
  24. Commandeering the controller: The ubiquitin-proteasome tug-of-war between coronavirus and host
    Yingjie Xiang, Qinyuan Zhu, Chunxiao Mou, Kaichuang Shi, Z F Chen · 2026 · Advances in virus research
  25. SARS-CoV-2 inhibits EBV-dependent tumor proliferation through PLpro-mediated degradation of EBNA1
    Liubing Du, Mengxuan Wang, Xue Liu, Ziliang Peng, Zhihui Zhang, Zhanjia Zhang, Zhijuan Liang, Qingrong Sun, Jiaxin Zhuang, Kongyang Ma et al. · 2026 · Acta Pharmaceutica Sinica B
  26. Recent Advances in the Design of Inhibitors Targeting the Viral Entry and Replication of the SARS-CoV-2 Virus, Driven by In Silico Approaches
    Phumelele Nodola, Patience Snenhlanhla Sthembile. Molefe, Potlaki Foster Tseki, Njabulo Joyfull Gumede · 2026 · Molecules
  27. Nanobodies targeting SARS-CoV-2 papain-like protease exert dual antiviral and anti-inflammatory effects
    Guolong Liu, Jiantao Chen, Fang Wu, Peilan Wei, Yuzhe Wu, Di Yan, Xinfeng Xu, Qiang Ding, Yanqun Wang, Shuwen Liu et al. · 2026 · Journal of Virology
  28. Integrated machine learning and structure-based discovery of noncovalent natural product inhibitors targeting SARS-CoV-2 papain-like protease
    Khulud Bukhari · 2026 · Journal of King Saud University: Science
  29. Hierarchical Computational Prioritization of Uvaria chamae Phytochemicals Targeting Ebola Virus Glycoprotein and SARS-CoV-2 PLpro
    Sédami Medegan Fagla, Toussaint Sovègnon, Mélaine Bete, Mariette Sanvi, Boris Brice Legba, Konei Emangbondji Hounsou, Jean Robert Klotoé, Victorien Tamègnon Dougnon · 2026 · Compounds
  30. BindingDB Entry 50022955: Design of inhibitors of SARS-CoV-2 papain-like protease deriving from GRL0617: Structure-activity relationships.
    BindingDB · 2026 · UC San Diego
  31. BindingDB Entry 50023088: Chemical Space Profiling of SARS-CoV-2 PLpro Using DNA-Encoded Focused Libraries.
    BindingDB · 2026 · UC San Diego
  32. BindingDB Entry 50020982: New Strategies for Responding to SARS-CoV-2: The Present and Future of Dual-Target Drugs.
    BindingDB · 2025 · UC San Diego
  33. BindingDB Entry 50023740: Development of acylhydrazone linked thiazoles as non-covalent dual inhibitors of SARS-CoV-2 proteases.
    BindingDB · 2026 · UC San Diego
  34. BindingDB Entry 50020820: SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads.
    BindingDB · 2024 · UC San Diego
  35. BindingDB Entry 50020959: Design, Synthesis, and Biological Evaluation of 1,2,4-Oxadiazole Derivatives Containing an Aryl Carboxylic Acid Moiety as Potent Sarbecovirus Papain-like Protease Inhibitors.
    BindingDB · 2025 · UC San Diego
  36. BindingDB Entry 50016899: Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease.
    BindingDB · 2023 · UC San Diego
  37. BindingDB Entry 50019858: Repurposing 1,2,4-oxadiazoles as SARS-CoV-2 PLpro inhibitors and investigation of their possible viral entry blockade potential.
    BindingDB · 2024 · UC San Diego
  38. BindingDB Entry 50015901: Chalcone-amide, a privileged backbone for the design and development of selective SARS-CoV/SARS-CoV-2 papain-like protease inhibitors.
    BindingDB · 2023 · UC San Diego
  39. BindingDB Entry 50018948: Design and synthesis of naturally-inspired SARS-CoV-2 inhibitors.
    BindingDB · 2024 · UC San Diego